Heron Therapeutics, Inc. (0J4V.L)

USD 2.08

(-7.79%)

Long Term Debt Summary of Heron Therapeutics, Inc.

  • Heron Therapeutics, Inc.'s latest annual long term debt in 2023 was 173.75 Million USD , up 16.39% from previous year.
  • Heron Therapeutics, Inc.'s latest quarterly long term debt in 2024 Q2 was 174.22 Million USD , up 0.14% from previous quarter.
  • Heron Therapeutics, Inc. reported annual long term debt of 149.28 Million USD in 2022, up 0.14% from previous year.
  • Heron Therapeutics, Inc. reported annual long term debt of 149.08 Million USD in 2021, up 923.84% from previous year.
  • Heron Therapeutics, Inc. reported quarterly long term debt of 174.22 Million USD for 2024 Q2, up 0.14% from previous quarter.
  • Heron Therapeutics, Inc. reported quarterly long term debt of 149.38 Million USD for 2023 Q2, up 0.03% from previous quarter.

Annual Long Term Debt Chart of Heron Therapeutics, Inc. (2023 - 2012)

Historical Annual Long Term Debt of Heron Therapeutics, Inc. (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 173.75 Million USD 16.39%
2022 149.28 Million USD 0.14%
2021 149.08 Million USD 923.84%
2020 14.56 Million USD 18.94%
2019 12.24 Million USD 0.0%
2018 - USD 0.0%
2017 - USD -100.0%
2016 50 Million USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Long Term Debt Comparison of Heron Therapeutics, Inc.

Name Long Term Debt Long Term Debt Difference
uniQure N.V. 130.06 Million USD -33.589%
Agios Pharmaceuticals, Inc. 56.98 Million USD -204.894%
Amicus Therapeutics, Inc. 387.85 Million USD 55.202%
Atara Biotherapeutics, Inc. 45.69 Million USD -280.262%
bluebird bio, Inc. 224.41 Million USD 22.577%
Cara Therapeutics, Inc. 37.07 Million USD -368.602%
Imunon, Inc. 1.13 Million USD -15150.949%
Editas Medicine, Inc. 24.37 Million USD -612.921%
IQVIA Holdings Inc. 12.95 Billion USD 98.659%
Mettler-Toledo International Inc. 1.97 Billion USD 91.205%
Myriad Genetics, Inc. 130.9 Million USD -32.737%
Neurocrine Biosciences, Inc. 258.3 Million USD 32.732%
Supernus Pharmaceuticals, Inc. 33.19 Million USD -423.415%
Verastem, Inc. 40.08 Million USD -333.451%
Walgreens Boots Alliance, Inc. 8.04 Billion USD 97.84%
Waters Corporation 2.3 Billion USD 92.464%
Thermo Fisher Scientific Inc. 31.3 Billion USD 99.445%
Biogen Inc. 7.18 Billion USD 97.583%
Nektar Therapeutics 112.62 Million USD -54.276%
Perrigo Company plc 3.63 Billion USD 95.217%
Dynavax Technologies Corporation 252.41 Million USD 31.165%
Illumina, Inc. 1.48 Billion USD 88.331%
Corbus Pharmaceuticals Holdings, Inc. 3.23 Million USD -5265.014%
Iovance Biotherapeutics, Inc. 1 Million USD -17275.3%
Unity Biotechnology, Inc. 23.53 Million USD -638.149%
BioMarin Pharmaceutical Inc. 593.09 Million USD 70.704%
Sangamo Therapeutics, Inc. 33.51 Million USD -418.434%
Evolus, Inc. 120.35 Million USD -44.362%
Adicet Bio, Inc. 17.7 Million USD -881.489%
Aclaris Therapeutics, Inc. 3.07 Million USD -5552.342%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD 93.572%
Esperion Therapeutics, Inc. 501.54 Million USD 65.357%
FibroGen, Inc. 89.69 Million USD -93.711%
Agilent Technologies, Inc. 2.73 Billion USD 93.647%
OPKO Health, Inc. 222.03 Million USD 21.745%
Homology Medicines, Inc. 43.17 Million USD -302.43%
Geron Corporation 35.05 Million USD -395.715%
Alnylam Pharmaceuticals, Inc. 2.34 Billion USD 92.584%
Exelixis, Inc. 189.94 Million USD 8.524%
Viking Therapeutics, Inc. 936 Thousand USD -18463.355%
Anavex Life Sciences Corp. - USD -Infinity%
Intellia Therapeutics, Inc. 96.74 Million USD -79.595%
Zoetis Inc. 6.56 Billion USD 97.353%
Axsome Therapeutics, Inc. 178.07 Million USD 2.424%
Abeona Therapeutics Inc. 4.4 Million USD -3847.138%
Vertex Pharmaceuticals Incorporated 724.7 Million USD 76.024%
Kala Pharmaceuticals, Inc. 34.19 Million USD -408.198%
Ionis Pharmaceuticals, Inc. 1.4 Billion USD 87.592%
Sarepta Therapeutics, Inc. 1.13 Billion USD 84.658%
Corcept Therapeutics Incorporated - USD -Infinity%
Halozyme Therapeutics, Inc. 1.49 Billion USD 88.411%
Blueprint Medicines Corporation 610.96 Million USD 71.561%
Insmed Incorporated 1.19 Billion USD 85.44%
TG Therapeutics, Inc. 100.11 Million USD -73.548%
Incyte Corporation 29.16 Million USD -495.82%
Emergent BioSolutions Inc. 446.5 Million USD 61.086%